YD Bio and EG BioMed Partner with JoiiUp to Launch AI-Driven Cancer Risk Assessment for Corporate Wellness Programs
Key Highlights
- ➤Assessment validated using over 1,200 clinical records from three TMU-affiliated hospitals
- ➤JoiiUp supports employee wellness programs for over 400 companies
- ➤YD Bio and EG BioMed integrate cancer risk assessment into JoiiSports app
- ➤Assessment analyzes ten cancer types using questionnaires and proprietary AI models
- ➤YD Bio expects EG BioMed merger to close in 2026, subject to conditions
Expert Statements
Dr. Ethan Shen, Chairman and CEO of YD Bio
“A key to cancer prevention is understanding risk early and taking timely action”
Dr. Ethan Shen, Chairman and CEO of YD Bio
“This Assessment is the first step in building a comprehensive cancer management pathway spanning risk assessment, early detection, and precision medicine.”
Dr. Ethan Shen, Chairman and CEO of YD Bio
“Through JoiiUp, we are bringing personalized risk analysis directly into everyday health management and supporting vital follow-up discussions with healthcare professionals.”
Dr. Ruo-Kai Lin, Professor at TMU and Chief of R&D at EG BioMed
“Through questionnaires and personalized analysis, we hope to help users understand their risks and inform discussions with healthcare professionals.”
Dr. Ruo-Kai Lin, Professor at TMU and Chief of R&D at EG BioMed
“Partnering with JoiiUp makes this clinically validated information vastly more accessible.”
TAIPEI, Taiwan, and BOTHELL, Wash., Oct. 20, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection and ophthalmologic innovations, today announced a strategic collaboration with EG BioMed Co., Ltd., a Taiwan registered company and an affiliate of YD Bio (“EG BioMed”), and digital health provider JoiiUp. The partnership integrates an AI Cancer Risk Assessment (the “Assessment”), jointly developed by YD Bio and EG BioMed, into JoiiUp’s JoiiSports app, expanding access to personalized health insights for corporate wellness programs and healthcare institutions.
Key Collaboration Highlights * Clinically Validated Data: The Assessment was developed in collaboration with three Taipei Medical University (TMU) affiliated hospitals and validated using over 1,200 clinical records. * Broad Immediate Reach: JoiiUp brings over 12 years of workplace health promotion experience, actively supporting the employee wellness programs of over 400 companies. * Non-Invasive Profiling: The tool utilizes an online health questionnaire and proprietary AI models mapped against medical literature to analyze demographic data, lifestyle habits, and family history across ten cancer types—requiring no blood draws or imaging. * Actionable Digital Integration: By leveraging Single Sign-On (SSO), users can seamlessly access the Assessment directly within the JoiiSports app to generate personalized risk reports and targeted lifestyle recommendations. Strategic Market Integration
Get started
Create a free account to read the full story.